Biocon inaugurates new manufacturing facility & product

For its insulin portfolio

Biocon inaugurated a world class facility for manufacturing new generation, patient friendly devices for its insulin portfolio. The company also launched Basalog One, a high end ready to use insulin glargine disposable pen for better blood sugar management for people with diabetes, manufactured in this facility.

Powered by Capital Market - Live News